Loading
Latest filing published 23 Apr 2026 for 梅花生物, €4.8M.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
何君 is a declared insider of 梅花生物 (senior executive), with filings sourced from SSE / SZSE (CSRC). In total, 2 filings cover trades dated from 20 May 2024 to 23 April 2026.
No open-market sale appears; the market trades are 2 purchases worth €5.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 23 April 2026: an open-market purchase of €4.8M, in 梅花生物. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.